A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, researchers said. The score could help better manage the follow-up care for ...

Sir Chris Hoy has revealed he is still reeling off the “worst crash I’ve ever had” as he continues his heart-wrenching battle with prostate cancer. The six-time Olympic cycling champion suffered the ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ...

In patients with biochemical failure after prostatectomy, about two thirds showed detectable local disease at restaging. Multiparametric MRI alone detected local lesions in over one third of patients ...

"Grey’s Anatomy" veteran James Pickens Jr. is opening up about his own real-life health diagnosis. Following the Thursday, Nov. 13 midseason finale episode, ABC aired a public service announcement ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

The 8-year overall survival rate was 78.9% with enzalutamide-leuprolide and 69.5% with leuprolide alone. Treatment with enzalutamide plus leuprolide reduces the risk of death by more than 40% in ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The combination ...

Reply to: Oxaliplatin Dosing and Toxicity: A Cautionary Perspective on Efficacy Biochemical recurrence (BCR) of prostate cancer (PCa) after definitive surgery and/or radiation (including salvage ...